Evaluation of bioactive glass for mastoid obliteration: A guinea pig model

In Vivo

Volumn 21, Issue 4, 2007, Pages 651-656

  Jang, Chul Ho ^a,b   Cho, Yong Bum ^a   Bae, Chun Sik ^c  

^a Chonnam National University Medical School   (South Korea)

^b Chosun Medical School   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Bioactive glass; Mastoid obliteration; New bone formation

Indexed keywords

GLASS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CARTILAGE CELL; CERAMIC PROSTHESIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOREIGN BODY REACTION; GUINEA PIG; HISTOPATHOLOGY; IMPLANTATION; MALE; MASTOIDECTOMY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PROSTHESIS MATERIAL;

EID: 34547801718     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shohet JA and de Jong AL: The management of pediatric cholesteatoma. Otolaryngol Clin North Am 35: 841-851, 2002.
2. Palva T: Surgical treatment of chronic middle ear disease. II. Canal wall up and canal wall down procedures. Acta Otolaryngol 104: 487-494, 1987.
3. Guilford FR: Obliteration of the cavity and reconstruction of the auditory canal in temporal bone surgery. Trans Am Acad Ophthal Otolaryngol 65: 114-122, 1961.
4. Hartwein J and Hormann K: A technique for the reconstruction of the posterior canal wall and mastoid obliteration in radical cavity surgery. Am J Otol 3: 169-173, 1990.
5. Pou JW: Reconstruction of bony canal wall with autogenous bony graft. Laryngoscope 87: 1826-1832, 1977.
6. Grote JJ and Van Bitterswijk CA: Reconstruction of the posterior auditory canal wall with a hydroxyapatite prosthesis. Ann Otol Rhinol Laryngol 95(Suppl): 6-9, 1986.
7. Gomez-Ullate R, Cristobal F, Ruiz C and Arcocha A: Mastoid obliteration in open cavities. Acta Otorrinolaringol Esp 48: 605-608, 1997.
8. Irving RM, Gray RF and Moffat DA: Bone pate obliteration or revision mastoidectomy: a five-symptom comparative study. Clin Otolaryngol 19: 158-160, 1994.
9. Montandon P, Benchaou M and Guyot JP: Modification canal wall-up mastoidectmoy with mastoid obliteration for severe chronic otitis media. Am J Otol 16: 99-103, 1995.
10. Jang CH: Changes in external ear resonance after mastoidectmoy: open cavity mastoid versus obliterated mastoid cavity. Clin Otolaryngol 27: 509-511, 2002.
11. Van Hasselt CA, Liu KC and Tong MC: The Hong Kong vascularized temporalis fascia flaps for optimal, mastoid cavity reconstruction. Laryngoscope 102: 289-299, 1992.
12. Cheney ML, Megerian CA, Brown MT, McKenna MJ and Nadol JB: The use of the temporoparietal fascial flap in temporal bone reconstruction. Am J Otol 17: 137-142, 1996.
13. Hench LL and West JK: Biological application of bioactive glasses. Life Chem Reports 13: 187-204, 1996.
14. Wilson J and Low SB: Bioactive ceramics for periodontal treatment: comparative studies in the Patus monkey. J Appl Biomater 3: 123-129, 1992.
15. Leatherman BD and Doruhoffer JL: Bioactive glass ceramic particles as an alternative for mastoid obliteration: results in an animal model. Otol Neurotol 23: 657-660, 2002.
16. Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, Tsuji E and Sugihara T: Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 334: 316-325, 1997.
17. Ousterhout DK and Steinicki EJ: Plastic surgery's plastics. Clin Plast Surg 23: 1831-1889, 1996.
18. Quinones CR and Lovelace TB: Utilization of a bioactive synthetic particulate for periodontal therapy and bone augmentation techniques. Pract Periodontics Aesthet Dent 9: 1-7, 1997.
19. Amato MM, Blaydon SM, Scribbick FW, Belden CJ, Shore JW, Neuhaus RW, Kelley PS and Holck DE: Use of bioglass for orbital volume augmentation in enophthalmos: A rabbit model (Oryctolagus Cuniculus). Ophthal Plast Reconstr Surg 6: 455-465, 2003.
20. Price N, Bendall SP, Frondoza C, Jinnah RH and Hungerford DS: Human osteoblast-like cells (MG63) proliferate on a bioactive glass surface. J Biomed Mater Res 37: 384-400, 1997.